JIM.fr
JIM.fr (Journal International de Médecine) is a French-language digital medical news platform serving French healthcare professionals with daily clinical updates, expert opinions, and continuing professional development (DPC) training, operating as part of the WebMD/Medscape network on a freemium model.
- Company typePrivate
- Founded1994
- HeadquartersParis, France
- Headcount1–10
- GTM typeB2C
- OfferingDigital Commerce or Content
What JIM.fr does
JIM.fr (Journal International de Médecine) is a French-language digital medical news and information platform serving healthcare professionals in France. Founded in 1994 and headquartered in Paris, JIM.fr provides daily medical news, clinical updates, expert opinions, congress coverage, and socio-professional content across medical specialties. The platform operates on a freemium model, offering free unlimited access to core medical content via website and Medscape-powered mobile applications (iOS/Android), with premium subscription tiers including JIM+ (opinion pieces, interviews, in-depth analysis) and JIMdpc (continuing professional development training and education credits required for French healthcare professional licensure).
The platform's core technology infrastructure is provided through its parent company relationship with WebMD LLC and integration into the WebMD/Medscape professional medical network. This includes shared authentication (SSO), hosting, content delivery systems, and distribution through Medscape's mobile applications. In 2026, JIM.fr added Medscape AI-powered search functionality enabling natural language retrieval across medical content. The platform distributes content through its website, email newsletters, and social media channels (LinkedIn, X, Facebook, Bluesky), targeting French-speaking doctors and medical professionals as a vertically segmented audience.
JIM.fr's business model centers on content-driven user acquisition and freemium monetization. Free registered membership drives traffic and engagement through editorial content, while premium JIM+ and JIMdpc offerings represent monetization extensions. The company operates with a small team (1-10 employees per firmographic data) and functions as an integrated digital media operation within WebMD's global health information network rather than as an independent standalone business.
JIM.fr firmographics
Firmographics- Name
- JIM.fr
- Legal name
- WebMD LLC
- Website
- https://jim.fr
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- JIM.fr (Journal International de Médecine) is a French-language digital medical news platform serving French healthcare professionals with daily clinical updates, expert opinions, and continuing professional development (DPC) training, operating as part of the WebMD/Medscape network on a freemium model.
- Ownership category
- akta.pro rank
JIM.fr industry classification
Industry- Product category
- Medical News & Information Services
- NAICS
- Periodical Publishers (513120)
- SIC
- Periodicals: Publishing Or Publishing & Printing (2721)
- akta.pro primary industry
- Medical & Clinical Reference (Physicians, Nursing, Allied Health) (EDAGAGAA)
- akta.pro secondary industry
- Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)
Keywords
Where JIM.fr is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Markets served
JIM.fr business model
Business model- GTM type
- B2C
- Offering type
- Digital Commerce or Content
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Freemium subscription model: Free access to core content with premium subscriptions for JIM+ and JIMdpc services. Users can register for free membership with access to medical news, while premium tiers offer additional content and features.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Annual | Free membership with access to medical news and content |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
JIM.fr product offering
Product offeringCore offering
JIM.fr is a French-language digital medical news platform that delivers daily medical news, clinical updates, expert opinions, congress coverage, and socio-professional information to French healthcare professionals. It operates a freemium model with free unlimited access to core medical content and premium subscriptions through the JIM+ section (opinion pieces, interviews, in-depth analysis) and JIMdpc continuing professional development platform.
Product overview
JIM.fr operates as a unified medical news platform serving French healthcare professionals, consisting of the core JIM.fr website for daily medical news, the JIM+ premium opinion and analysis section, and the JIMdpc continuing professional development platform. The platform is accessible via web and mobile applications (iOS/Android through the Medscape app), and features Medscape AI-powered search functionality.
Differentiator
Problem solved
Functional benefit
Brands
- JIM+: Premium content section featuring opinion pieces, interviews, and in-depth analysis
- JIMdpc
Products and services
- JIM.fr JIM.fr (Journal International de Médecine) is a French-language medical news website providing medical professionals with daily news articles, clinical updates, and professional content across multiple specialties, including medical news, socio-professional news, and congress coverage.
- JIM+ JIM+ is a premium content section featuring opinion pieces, interviews, quizzes, and in-depth analysis on healthcare policy and medical practice topics for French healthcare professionals.
- JIMdpc JIMdpc is a continuing professional development (DPC) platform for French healthcare professionals, providing training programs and education credits required for ongoing professional certification.
- Medscape Mobile App (iOS/Android) JIM.fr is accessible via Medscape mobile applications for iOS and Android devices, available on the App Store and Google Play, providing healthcare professionals with on-the-go access to medical news and content.
Companies that use JIM.fr
Customer profileSegments1 record
Ideal customer profiles1 record
JIM.fr technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature1 record
JIM.fr partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- WebMD / MedscapecoreJIM.fr operates as part of the WebMD/Medscape professional medical network, utilizing their platform infrastructure for content delivery, authentication (SSO), and mobile applications. The site powers JIM's digital presence with technology, hosting, and distribution capabilities.
Scale indicators1 record
Recent moves5 records
Expansion highlights5 records
JIM.fr competitors and assessment
Company assessmentBroad incumbents
- Medscape: Global medical news and education platform owned by WebMD that provides the underlying technology, mobile apps, and AI search used by JIM.fr — overlapping audience but operating at much larger scale across multiple geographies and languages.
- BMJ (British Medical Journal): International peer-reviewed medical journal and professional publishing group providing research, news and CME to physicians globally — comparable in clinical-reference and CME delivery to JIM.fr's content mix, though broader in scope and English-language.
- New England Journal of Medicine (NEJM): Leading international peer-reviewed medical journal providing clinical research and physician-facing content, including CME — comparable as a high-credential professional medical reference publisher serving the same physician audience as JIM.fr.
- The Lancet: Internationally recognised peer-reviewed medical journal with associated news and comment content for healthcare professionals — comparable to JIM.fr as a professional medical publishing and reference brand.
- WebMD: US-headquartered parent of JIM.fr and Medscape; provides infrastructure and distribution to JIM.fr while also being a global consumer and professional health information platform operating well beyond the French HCP niche.
Regional players
- Doctissimo: Major French consumer health information portal owned by Doctissimo/Femme Actuelle group; adjacent to JIM.fr in French health publishing but serving consumer patients rather than HCPs, and overlapping in French-language health media.
Direct peers
- What's Up Doc: French-language medical magazine and platform targeted at younger and practising physicians, providing news, lifestyle and professional content in a similar HCP media format to JIM.fr.
- Egora: French medical news and information portal serving healthcare professionals with daily news, clinical updates, and professional content — the closest French-language HCP news competitor to JIM.fr.
- Le Quotidien du Médecin: Long-established French daily newspaper for physicians covering medical news, professional issues and clinical updates — directly comparable in audience and editorial mix to JIM.fr.
- La Revue du Praticien: Reference medical journal for French physicians with continuing medical education content — directly comparable to JIM.fr on professional medical reference publishing and CME delivery.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks4 records
Key highlights5 records
Customer concentration
JIM.fr social profiles
Digital presenceJIM.fr financial estimates
Financial estimateRevenue estimate
Valuation estimate
JIM.fr leadership team
Management profileNumber of profiles
Profiles1 record
JIM.fr subsidiaries and ownership
Company hierarchySubsidiaries1 record
JIM.fr funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
JIM.fr M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about JIM.fr
What does JIM.fr do?
JIM.fr is a French-language digital medical news platform that delivers daily medical news, clinical updates, expert opinions, congress coverage, and socio-professional information to French healthcare professionals. It operates a freemium model with free unlimited access to core medical content and premium subscriptions through the JIM+ section (opinion pieces, interviews, in-depth analysis) and JIMdpc continuing professional development platform.
Is JIM.fr a public or private company?
JIM.fr is a private company. It is classified as corporate owned and is currently operating.
When was JIM.fr founded?
JIM.fr was founded in 1994. It employs 1 to 10 people.
Where is JIM.fr based?
JIM.fr is headquartered in Paris, France, in the Europe region.
How does JIM.fr make money?
One revenue line is on record: freemium subscription model.
Who are JIM.fr's main competitors?
Broad incumbents on record are Medscape, BMJ (British Medical Journal), New England Journal of Medicine (NEJM), The Lancet and WebMD. Doctissimo is listed as a regional player. Direct peers are What's Up Doc, Egora, Le Quotidien du Médecin and La Revue du Praticien.
Does JIM.fr have an API?
No public API is recorded for JIM.fr.
What industry is JIM.fr in?
JIM.fr's product category is Medical News & Information Services. Its primary akta.pro industry code is EDAGAGAA, Medical & Clinical Reference (Physicians, Nursing, Allied Health), with a secondary code of EDAGANAJ, Healthcare & Clinical Professional Development (CME/CE). Its NAICS code is 513120 and its SIC code is 2721.